|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Cardiac troponin I (cTnI) is a phosphoprotein subunit of the troponin-tropomyosin complex that is thought to inhibit cardiac muscle contraction during diastole. To investigate the contributions of cTnI phosphorylation to cardiac regulation, transgenic mice were created with the phosphorylation sites of cTnI mutated to alanine. Activation of protein kinase C (PKC) by perfusion of hearts with phorbol-12-myristate-13-acetate (PMA) or endothelin-1 (ET-1) inhibited the maximum ATPase rate by up to 25 % and increased the Ca2+ sensitivity of ATPase activity and of isometric tension by up to 0.15 pCa units. PKC activation no longer altered cTnI phosphorylation, depressed ATPase rates or enhanced myofilament Ca2+ sensitivity in transgenic mice expressing cTnI that could not be phosphorylated on serines43/45 and threonine144 (PKC sites). Modest changes in myosin regulatory light chain phosphorylation occurred in all mouse lines, but increases in myofilament Ca2+ sensitivity required the presence of phosphorylatable cTnI. For comparison, the-adrenergic agonist isoproterenol caused a 38 % increase in maximum ATPase rate and a 0.12 pCa unit decrease in myofilament Ca2+ sensitivity. These
-adrenergic effects were absent in transgenic mice expressing cTnI that could not be phosphorylated on serines23/24 (protein kinase A, PKA, sites). Overall, the results indicate that PKC and PKA exert opposing effects on actomyosin function by phosphorylating cTnI on distinct sites. A primary role of PKC phosphorylation of cTnI may be to reduce the requirements of the contractile apparatus for both Ca2+ and ATP, thereby promoting efficient ATP utilisation during contraction.
This article has been cited by other articles:
![]() |
K. A. Sheehan, Y. Ke, B. M. Wolska, and R. J. Solaro Expression of active p21-activated kinase-1 induces Ca2+ flux modification with altered regulatory protein phosphorylation in cardiac myocytes Am J Physiol Cell Physiol, January 1, 2009; 296(1): C47 - C58. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Zabrouskov, Y. Ge, J. Schwartz, and J. W. Walker Unraveling Molecular Complexity of Phosphorylated Human Cardiac Troponin I by Top Down Electron Capture Dissociation/Electron Transfer Dissociation Mass Spectrometry Mol. Cell. Proteomics, October 1, 2008; 7(10): 1838 - 1849. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. P. Sumandea, V. O. Rybin, A. C. Hinken, C. Wang, T. Kobayashi, E. Harleton, G. Sievert, C. W. Balke, S. J. Feinmark, R. J. Solaro, et al. Tyrosine Phosphorylation Modifies Protein Kinase C {delta}-dependent Phosphorylation of Cardiac Troponin I J. Biol. Chem., August 15, 2008; 283(33): 22680 - 22689. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z.-F. Lai, Y.-Z. Chen, L.-P. Feng, X.-M. Meng, J.-F. Ding, L.-Y. Wang, J. Ye, P. Li, X.-S. Cheng, Y. Kitamoto, et al. Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury Am J Physiol Heart Circ Physiol, August 1, 2008; 295(2): H708 - H716. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Avkiran, A. J. Rowland, F. Cuello, and R. S. Haworth Protein Kinase D in the Cardiovascular System: Emerging Roles in Health and Disease Circ. Res., February 1, 2008; 102(2): 157 - 163. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. A. Sheehan, Y. Ke, and R. J. Solaro p21-Activated kinase-1 and its role in integrated regulation of cardiac contractility Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R963 - R973. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Stelzer, J. R. Patel, J. W. Walker, and R. L. Moss Differential Roles of Cardiac Myosin-Binding Protein C and Cardiac Troponin I in the Myofibrillar Force Responses to Protein Kinase A Phosphorylation Circ. Res., August 31, 2007; 101(5): 503 - 511. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kang, K. Y. Chung, and J. W. Walker G-Protein Coupled Receptor Signaling in Myocardium: Not for the Faint of Heart Physiology, June 1, 2007; 22(3): 174 - 184. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. C. Bilchick, J. G. Duncan, R. Ravi, E. Takimoto, H. C. Champion, W. D. Gao, L. B. Stull, D. A. Kass, and A. M. Murphy Heart failure-associated alterations in troponin I phosphorylation impair ventricular relaxation-afterload and force-frequency responses and systolic function Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H318 - H325. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Stelzer, J. R. Patel, and R. L. Moss Acceleration of Stretch Activation in Murine Myocardium due to Phosphorylation of Myosin Regulatory Light Chain J. Gen. Physiol., August 28, 2006; 128(3): 261 - 272. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Sahin, H. Shu, J. Fernandez, A. El-Armouche, J. D. Molkentin, A. C. Nairn, and J. A. Bibb Phosphorylation of Protein Phosphatase Inhibitor-1 by Protein Kinase C J. Biol. Chem., August 25, 2006; 281(34): 24322 - 24335. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Proven, H. L. Roderick, S. J. Conway, M. J. Berridge, J. K. Horton, S. J. Capper, and M. D. Bootman Inositol 1,4,5-trisphosphate supports the arrhythmogenic action of endothelin-1 on ventricular cardiac myocytes J. Cell Sci., August 15, 2006; 119(16): 3363 - 3375. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kang and J. W. Walker Endothelin-1 and PKC Induce Positive Inotropy Without Affecting pHi in Ventricular Myocytes. Experimental Biology and Medicine, June 1, 2006; 231(6): 865 - 870. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Cazorla, S. Szilagyi, N. Vignier, G. Salazar, E. Kramer, G. Vassort, L. Carrier, and A. Lacampagne Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice Cardiovasc Res, February 1, 2006; 69(2): 370 - 380. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. V. Westfall, A. M. Lee, and D. A. Robinson Differential Contribution of Troponin I Phosphorylation Sites to the Endothelin-modulated Contractile Response J. Biol. Chem., December 16, 2005; 280(50): 41324 - 41331. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Layland, R. J. Solaro, and A. M. Shah Regulation of cardiac contractile function by troponin I phosphorylation Cardiovasc Res, April 1, 2005; 66(1): 12 - 21. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Haddad, B. R. Coleman, A. Zhao, and K. N. Blackwell Regulation of atrial contraction by PKA and PKC during development and regression of eccentric cardiac hypertrophy Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H695 - H704. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sakthivel, N. L. Finley, P. R. Rosevear, J. N. Lorenz, J. Gulick, S. Kim, P. VanBuren, L. A. Martin, and J. Robbins In Vivo and in Vitro Analysis of Cardiac Troponin I Phosphorylation J. Biol. Chem., January 7, 2005; 280(1): 703 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Ashley, J. Powers, M. Chen, R. Kundu, T. Finsterbach, A. Caffarelli, A. Deng, J. Eichhorn, R. Mahajan, R. Agrawal, et al. The endogenous peptide apelin potently improves cardiac contractility and reduces cardiac loading in vivo Cardiovasc Res, January 1, 2005; 65(1): 73 - 82. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. S. Haworth, F. Cuello, T. J. Herron, G. Franzen, J. C. Kentish, M. Gautel, and M. Avkiran Protein Kinase D Is a Novel Mediator of Cardiac Troponin I Phosphorylation and Regulates Myofilament Function Circ. Res., November 26, 2004; 95(11): 1091 - 1099. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. B. Roman, P. H. Goldspink, E. Spaite, D. Urboniene, R. McKinney, D. L. Geenen, R. J. Solaro, and P. M. Buttrick Inhibition of PKC phosphorylation of cTnI improves cardiac performance in vivo Am J Physiol Heart Circ Physiol, June 1, 2004; 286(6): H2089 - H2095. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Metzger and M. V. Westfall Covalent and Noncovalent Modification of Thin Filament Action: The Essential Role of Troponin in Cardiac Muscle Regulation Circ. Res., February 6, 2004; 94(2): 146 - 158. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. Marston and C. S. Redwood Modulation of Thin Filament Activation by Breakdown or Isoform Switching of Thin Filament Proteins: Physiological and Pathological Implications Circ. Res., December 12, 2003; 93(12): 1170 - 1178. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |